← All stories
Markets
Putting innovation—and patients—in focus: A conversation with Astellas Pharma CEO Naoki Okamura
The Tokyo-based biopharmaceutical company is accelerating its pipeline by innovating at the intersection of biology, modality, and disease.
Covered by 1 outlet
All coverage · 1 article